Novartis AG (NVS) Q1 2021 Earnings Results

Novartis Misses on EPS, Stock Down 1.33%

The earnings report indicates that Novartis faced some headwinds, resulting in a slight miss on EPS. The stock reacted negatively, dropping 1.33%. Investors may be concerned about the lack of guidance and the challenges mentioned by management, which could impact future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.52	N/A	-3.18%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious outlook due to market conditions but remains committed to advancing their product pipeline.

Management highlighted ongoing challenges in the market.

They emphasized a focus on innovation and pipeline development.

Novartis Misses on EPS, Stock Down 1.33%

Key numbers

Management commentary

Novartis AG

More earnings this week

Novartis Misses on EPS, Stock Down 1.33%

Key numbers

Management commentary